ViTAA Medical reports FDA clearance marks a pivotal milestone in ViTAA’s broader AiORTA™ suite, designed to support physicians across the full continuum of aortic care.
November 12, 2025
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
ViTAA Medical reports FDA clearance marks a pivotal milestone in ViTAA’s broader AiORTA™ suite, designed to support physicians across the full continuum of aortic care.